| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,489,000 | 2,846,000 | 3,423,000 | 2,999,000 | | Cost of Revenue | 307,000 | 2,490,000 | 1,872,000 | 3,799,000 | | | Gross Profit | 3,182,000 | 356,000 | 1,551,000 | (800,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,297,000 | (313,000) | 1,040,000 | (1,368,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 200,000 | 197,000 | 192,000 | 186,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 307,000 | 472,000 | 319,000 | 382,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 | 16,000 | 2,000 | 9,000 | | Earnings Before Interest And Taxes | 318,000 | 482,000 | 327,000 | (135,000) | | Interest Expense | 162,000 | 155,000 | 144,000 | 151,000 | | Income Before Tax | 156,000 | 327,000 | 183,000 | (286,000) | | Income Tax Expense | 195,000 | 180,000 | (6,000) | 78,000 | | Minority Interest |
-
|
-
|
-
| (2,000) | | | | Net Income From Continuing Ops | 339,000 | 153,000 | 183,000 | 160,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 339,000 | 153,000 | 183,000 | 160,000 | | Preferred Stock And Other Adjustments | (9,000) | 3,000 | (3,000) |
-
| | | Net Income Applicable To Common Shares | $330,000 | $156,000 | $180,000 | $160,000 |
|
0.11% Nasdaq 0.00%
Income Statement
